Literature DB >> 17384990

Hyaline globule-like structures in undifferentiated sarcoma cells of malignant müllerian mixed tumor of the fallopian tube.

Naoto Kuroda1, Yasunobu Inui, Masahiko Ohara, Takashi Hirouchi, Keiko Mizuno, Ayumi Kubo, Yoshihiro Hayashi, Hideaki Enzan, Gang-Hong Lee.   

Abstract

Malignant müllerian mixed tumors (MMMTs) of the fallopian tube are very rare neoplasms, and we present such a case with unusual findings here. A 57-year-old Japanese woman, after she received a medical checkup, underwent salpingo-oophorectomy on the suspicion of ovarian cancer. At the time of operation, the main tumor was present predominantly in the fallopian tube. Microscopically, the tumor consisted of carcinoma and sarcoma components. The carcinoma showed moderately to poorly differentiated adenocarcinoma. The sarcoma consisted of predominantly undifferentiated sarcoma and focally rhabdomyosarcomatous cells with abundant eosinophilic cytoplasm. Immunohistochemically, the differentiation toward rhabdomyosarcoma was confirmed. Interestingly, the cytoplasm of undifferentiated sarcoma cells contained hyaline globule-like structures. These structures showed a positive reaction for PAS, and these structures were not digested by the diastase pretreatment. Ultrastructurally, hyaline globule-like structures corresponded to lysosomes. Finally, pathologists should keep in mind that undifferentiated sarcoma cells in MMMT of the fallopian tube may contain hyaline globule-like structures in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384990     DOI: 10.1007/s00795-006-0327-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  13 in total

1.  Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.

Authors:  C Stumptner; H Heid; A Fuchsbichler; H Hauser; H J Mischinger; K Zatloukal; H Denk
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Eosinophilic cytoplasmic inclusions in papillary renal cell carcinoma.

Authors:  Naoyuki Danbara; Nobuaki Shikata; Hiroshi Kawamura; Masayuki Shintaku; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2005-12       Impact factor: 2.309

3.  Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases.

Authors:  Bhuvaneswari Krishnan; Luan D Truong
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

4.  Mesodermal mixed tumor primary in the fallopian tube.

Authors:  M Kinoshita; S Asano; M Yamashita; T Matsuda
Journal:  Gynecol Oncol       Date:  1989-03       Impact factor: 5.482

Review 5.  Malignant mixed müllerian tumor of the oviduct.

Authors:  I M Seraj; A King; D Chase
Journal:  Gynecol Oncol       Date:  1990-05       Impact factor: 5.482

6.  Carcinosarcomas and mixed Müllerian tumors of the fallopian tube.

Authors:  H G Muntz; J L Rutgers; H M Tarraza; A F Fuller
Journal:  Gynecol Oncol       Date:  1989-07       Impact factor: 5.482

7.  Myofibrosarcoma (low-grade myofibroblastic sarcoma) with intracytoplasmic hyaline (fibroma-like) inclusion bodies.

Authors:  Ricardo González-Cámpora; Antonio García Escudero; Juan José Ríos Martín; José Ramón Armas Padrón; Alberto Hevia Vázquez; Francisco José Vázquez Ramírez
Journal:  Ultrastruct Pathol       Date:  2003 Jan-Feb       Impact factor: 1.094

8.  Collecting duct carcinoma exhibiting diastase-resistant PAS-positive globular cytoplasmic inclusions and rhabdoid features arising in adult polycystic kidney disease: a case report.

Authors:  Naoto Kuroda; Hirofumi Satake; Eriko Miyazaki; Yoshihiro Hayashi; Makoto Hiroi; Hideaki Enzan
Journal:  Int J Surg Pathol       Date:  2004-04       Impact factor: 1.271

Review 9.  Malignant mixed müllerian tumor of the fallopian tube.

Authors:  J A Carlson; B L Ackerman; J E Wheeler
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

10.  Intracytoplasmic eosinophilic hyaline globules in cartilaginous neoplasms: a surgical, pathological, ultrastructural, and electron probe x-ray microanalytic study.

Authors:  A D del Rosario; H X Bui; J Singh; R Ginsburg; J S Ross
Journal:  Hum Pathol       Date:  1994-12       Impact factor: 3.466

View more
  6 in total

1.  Immunohistochemical and electron microscopic observations of stromal cells in the human oviduct mucosa.

Authors:  Haruo Hagiwara; Nobuo Ohwada; Takeo Aoki; Takeshi Suzuki; Kuniaki Takata
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

2.  Signet-ring stromal tumor of the ovary: an immunohistochemical and ultrastructural study with a review of the literature.

Authors:  Manabu Matsumoto; Yoshihiro Hayashi; Yuji Ohtsuki; Nobuo Ikegami; Makoto Toi; Mitsuko Iguchi; Makoto Hiroi
Journal:  Med Mol Morphol       Date:  2008-09-20       Impact factor: 2.309

3.  Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.

Authors:  Naoto Kuroda; Yoshiko Agatsuma; Masato Tamura; Petr Martinek; Ondrej Hes; Michal Michal
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Anaplastic carcinoma of the pancreas with rhabdoid features and hyaline globule-like structures.

Authors:  Naoto Kuroda; Shin-Ichi Iwamura; Nokiaki Fujishima; Masahiko Ohara; Takashi Hirouchi; Keiko Mizuno; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

5.  Oncogenic Activation of the Wnt/β-Catenin Signaling Pathway in Signet Ring Stromal Cell Tumor of the Ovary.

Authors:  Janusz Kopczynski; Artur Kowalik; Małgorzata Chłopek; Zeng-Feng Wang; Stanisław Góźdź; Jerzy Lasota; Markku Miettinen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016 May-Jun

6.  Malignant mixed Müllerian tumor of the fallopian tube: Case report and literature review.

Authors:  Alexandra Lavinia Cozlea; Mihai Gheorghe; Szilard Leo Kiss; Anas Fandi; Mihai Stanca; Simona Mocan; Mihai Emil Căpîlna; Nicolae Bacalbașa; Andreea Anamaria Moldovan
Journal:  Exp Ther Med       Date:  2021-12-28       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.